Skye Bioscience, Inc. (SKYE)
0.649
-0.01
(-0.95%)
USD |
NASDAQ |
Mar 20, 16:00
0.6363
-0.01
(-1.96%)
After-Hours: 20:00
Skye Bioscience Market Cap : 20.81M for March 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Halozyme Therapeutics, Inc. | 7.486B |
| Merck & Co., Inc. | 282.30B |
| SIGA Technologies, Inc. | 353.92M |
| ACADIA Pharmaceuticals, Inc. | 3.536B |
| Alnylam Pharmaceuticals, Inc. | 41.40B |
Market Cap Related Metrics
| PEG Ratio | -0.0049 |
| Price to Book Value | 1.039 |
| Price | 0.649 |
| Earnings Yield | -217.3% |
| PEGY Ratio | -0.0049 |